Jentadueto
Indicated to manage glycemic control in adults and developed to support blood glucose reduction in type 2 diabetes.
- Category
- Diabetes Management
- Active ingredients
- Linagliptin · Metformin
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 2.5/500mg
Jentadueto details
- Condition
- Type 2 Diabetes Mellitus
- Therapeutic class
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitor / Biguanide
- Pharmacological class
- DPP-4 Inhibitor / Biguanide
- Contraindications
- diabetic ketoacidosis; severe renal impairment; acute metabolic acidosis
- Minor side effects
- nausea; diarrhoea; abdominal pain
- Moderate side effects
- hypoglycaemia; headache
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Boehringer Ingelheim
- Onset Time
- 1–2 weeks
- Duration
- continuous
- Storage instructions
- Store below 30°C.
- Drug interactions
- iodinated contrast media
- Age restrictions
- Not for children.
- Pregnancy and breastfeeding
- Pregnancy: Not recommended. Breastfeeding: Not recommended.
Precautions and warnings
risk of lactic acidosis; monitor kidney function; discontinue before contrast imaging
Serious side effects
lactic acidosis, requires immediate medical attention; pancreatitis, requires immediate medical attention
Patient summary
indicated to manage glycemic control in adults and developed to support blood glucose reduction in type 2 diabetes.
Mechanism of action
Combines a DPP-4 inhibitor, which increases incretin hormone levels, with metformin, which decreases hepatic glucose production and improves insulin sensitivity, enhancing overall glycaemic control.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Jentadueto
Jentadueto is a combination therapy containing linagliptin and metformin, used to support the management of Type 2 Diabetes Mellitus. Produced by Boehringer Ingelheim, this medication assists in maintaining stable blood glucose levels and is provided as a tablet in the 2.5/500mg strength.
Buying Jentadueto online
Jentadueto is registered across 14 markets including the UAE, Singapore and Hong Kong, with availability also in Thailand, Malaysia and the Philippines. As one of the most ordered diabetes support medications across the region, it helps expats and local residents maintain consistent therapy when regional stock levels vary. Accessing the brand through established online channels provides a reliable way to manage individual health requirements while living or working abroad.